Pharmacovigilance and Drug Safety Software Market to Reach US$ 14.98 Billion by 2033 as AI-Driven Drug Monitoring Advances
According to DataM Intelligence, the global pharmacovigilance and drug safety software market was valued at US$ 7.56 billion in 2025 and is projected to reach US$ 14.98 billion by 2033, registering a CAGR of 10.8% during 2026-2033. Market expansion is
Brief summary
What this story is about
According to DataM Intelligence, the global pharmacovigilance and drug safety software market was valued at US$ 7.56 billion in 2025 and is projected to reach US$ 14.98 billion by 2033, registering a CAGR of 10.8% during 2026-2033. Market expansion is
Why it matters
Reader takeaways
- Use this brief as a quick orientation layer, then open the original source for the complete report.
- Tags and topic links help connect this story with related Oracle ecosystem coverage.
- Save the item if it affects your learning plan, architecture roadmap, or operational watchlist.
SEO context
Topic and keyword map
This brief is filed under Oracle ecosystem, partners and industry coverage.
health & medicineOracle ecosystem newsOracle partnersOracle customer storiesOracle integrationsenterprise technology news